|
2022 Journal Article Understanding the pathogenesis of occupational coal and silica dust-associated lung diseaseVanka, Kanth Swaroop, Shukla, Shakti, Gomez, Henry M., James, Carole, Palanisami, Thava, Williams, Kenneth, Chambers, Daniel C., Britton, Warwick J., Ilic, Dusan, Hansbro, Philip Michael and Horvat, Jay Christopher (2022). Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. European Respiratory Review, 31 (165) 210250, 1-17. doi: 10.1183/16000617.0250-2021 |
|
2022 Journal Article Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et alHua, Jeremy Tang, Zell-Baran, Lauren, Go, Leonard H T., Kramer, Mordechai R, Van Bree, Johanna B, Chambers, Daniel, Newbigin, Katrina, Deller, David, Matula, Michael, Fireman, Elizabeth, Dahbash, Mor, Martinez-Gonzalez, Cristina, León-Jimenez, Antonio, Sack, Coralynn, Ferrer Sancho, Jaume, Villar, Ana, Almberg, Kirsten S., Cohen, Robert A. and Rose, Cecile S (2022). Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et al. Occupational and Environmental Medicine, 79 (12), 849-850. doi: 10.1136/oemed-2022-108512 |
|
2022 Journal Article A phase IIb randomized study of an anti-αvβ6 monoclonal antibody in idiopathic pulmonary fibrosisRaghu, Ganesh, Mouded, Majd, Chambers, Daniel C., Martinez, Fernando J., Richeldi, Luca, Lancaster, Lisa H., Hamblin, Mark J., Gibson, Kevin F., Rosas, Ivan O., Prasse, Antje, Zhao, Guolin, Serenko, Michael, Novikov, Natasha, McCurley, Amy, Bansal, Prashant, Stebbins, Christopher, Arefayene, Million, Ibebunjo, Stella, Violette, Shelia M., Gallagher, Diana and Behr, Jürgen (2022). A phase IIb randomized study of an anti-αvβ6 monoclonal antibody in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine, 206 (9), 1128-1139. doi: 10.1164/rccm.202112-2824OC |
|
2022 Journal Article Towards truly ‘idiopathic’ pulmonary fibrosisMackintosh, John A. and Chambers, Daniel C. (2022). Towards truly ‘idiopathic’ pulmonary fibrosis. Respirology, 27 (9), 682-683. doi: 10.1111/resp.14320 |
|
2022 Journal Article Phase 2B study of inhaled RVT-1601 for chronic cough in idiopathic pulmonary fibrosis: a multicenter, randomized, placebo-controlled study (SCENIC Trial)Martinez, Fernando J., Wijsenbeek, Marlies S., Raghu, Ganesh, Flaherty, Kevin R., Maher, Toby M., Wuyts, Wim A., Kreuter, Michael, Kolb, Martin, Chambers, Daniel C., Fogarty, Charles, Mogulkoc, Nesrin, Tutuncu, Ahmet S. and Richeldi, Luca (2022). Phase 2B study of inhaled RVT-1601 for chronic cough in idiopathic pulmonary fibrosis: a multicenter, randomized, placebo-controlled study (SCENIC Trial). American Journal of Respiratory and Critical Care Medicine, 205 (9), 1084-1092. doi: 10.1164/rccm.202106-1485OC |
|
2022 Conference Publication Clinical Utility of a Standardized HP Exposure QuestionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T. J., Bastiampillai, S. A., Frenkel, S., Westall, G., Collard, H. R. and Glaspole, I. (2022). Clinical Utility of a Standardized HP Exposure Questionnaire. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2022. NEW YORK: AMER THORACIC SOC. |
|
2022 Conference Publication Australia and New Zealand Interstitial Lung Disease Registry (ANZ ILD) 2021 Update - Progress During the PandemicMoore, I., Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, I., Grainge, C., Wilsher, M. L., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. J. (2022). Australia and New Zealand Interstitial Lung Disease Registry (ANZ ILD) 2021 Update - Progress During the Pandemic. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2022. NEW YORK: AMER THORACIC SOC. |
|
2022 Journal Article Markers of rejection of a lung allograft: state of the artSilva, Tharushi de, Voisey, Joanne, Hopkins, Peter, Apte, Simon, Chambers, Daniel and O'Sullivan, Brendan (2022). Markers of rejection of a lung allograft: state of the art. Biomarkers in Medicine, 16 (6), 483-498. doi: 10.2217/bmm-2021-1013 |
|
2022 Journal Article Genomic lung allograft surveillance: is it primer time?Mackintosh, John A. and Chambers, Daniel C. (2022). Genomic lung allograft surveillance: is it primer time?. The Journal of Heart and Lung Transplantation, 41 (4), 467-469. doi: 10.1016/j.healun.2022.01.016 |
|
2022 Conference Publication Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national populationChee, M., Corte, T., Jackson, D., Lee, C., Wrobel, J., Glaspole, , Grainge, C., Wilsher, M., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Thien, F. (2022). Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national population. HOBOKEN: WILEY. |
|
2022 Conference Publication Polygenic risk scores in familial IPF implicates rare variantsLucas, S., Raspin, K., Chambers, D., Glaspole, , Reynolds, P., Schwartz, D., Walters, H., Wood-Baker, R., Walsh, S., Moodley, Y., Corte, T. and Dickinson, J. (2022). Polygenic risk scores in familial IPF implicates rare variants. HOBOKEN: WILEY. |
|
2022 Conference Publication Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T., Bastiampillai, S., Frenkel, S., Westall, G., Collard, H. and Glaspole, (2022). Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaire. HOBOKEN: WILEY. |
|
2022 Conference Publication Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemicMoore, , Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, , Grainge, C., Wilsher, M., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. (2022). Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemic. HOBOKEN: WILEY. |
|
2022 Journal Article Alveolar crystal burden in stone workers with artificial stone silicosisApte, Simon H., Tan, Maxine E., Lutzky, Viviana P., De Silva, Tharushi A., Fiene, Andreas, Hundloe, Justin, Deller, David, Sullivan, Clair, Bell, Peter T. and Chambers, Daniel C. (2022). Alveolar crystal burden in stone workers with artificial stone silicosis. Respirology, 27 (6), 437-446. doi: 10.1111/resp.14229 |
|
2022 Journal Article Effect of 2D and 3D culture microenvironments on mesenchymal stem cell-derived extracellular vesicles potenciesKusuma, Gina D., Li, Anqi, Zhu, Dandan, McDonald, Hannah, Inocencio, Ishmael M., Chambers, Daniel C., Sinclair, Kenneth, Fang, Haoyun, Greening, David W., Frith, Jessica E. and Lim, Rebecca (2022). Effect of 2D and 3D culture microenvironments on mesenchymal stem cell-derived extracellular vesicles potencies. Frontiers in Cell and Developmental Biology, 10 819726, 819726. doi: 10.3389/fcell.2022.819726 |
|
2022 Journal Article Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosisHua, Jeremy Tang, Zell-Baran, Lauren, Go, Leonard H. T., Kramer, Mordechai R., Van Bree, Johanna B., Chambers, Daniel, Deller, David, Newbigin, Katrina, Matula, Michael, Fireman, Elizabeth, Dahbash, Mor, Martinez-Gonzalez, Cristina, León-Jimenez, Antonio, Sack, Coralynn, Ferrer, Jaume, Villar, Ana, Almberg, Kirsten S., Cohen, Robert A. and Rose, Cecile S. (2022). Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis. Occupational and Environmental Medicine, 79 (9) 108190, 586-593. doi: 10.1136/oemed-2021-108190 |
|
2021 Journal Article TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisMacKintosh, John A., Pietsch, Maria, Lutzky, Viviana, Enever, Debra, Bancroft, Sandra, Apte, Simon H., Tan, Maxine, Yerkovich, Stephanie T., Dickinson, Joanne L., Pickett, Hilda A., Selvadurai, Hiran, Grainge, Christopher, Goh, Nicole S., Hopkins, Peter, Glaspole, Ian, Reynolds, Paul N., Wrobel, Jeremy, Jaffe, Adam, Corte, Tamera J. and Chambers, Daniel C. (2021). TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respiratory Research, 8 (1) e001127, 1-8. doi: 10.1136/bmjresp-2021-001127 |
|
2021 Journal Article The evolution of the ISHLT transplant registry : preparing for the futureStehlik, Josef, Christie, Jason D, Goldstein, Daniel R, Amarelli, Cristiano, Bertolotti, Alejandro, Chambers, Daniel C., Dorent, Richard, Gonzalez-Vilchez, Francisco, Parameshwar, Jayan, Perch, Michael, Zuckermann, Andreas, Coll, Elisabeth, Levy, Robert D., Atik, Fernando A., Gomez-Mesa, Juan Esteban, Moayedi, Yasbanoo, Peled-Potashnik, Yael, Schultz, Greg, Cherikh, Wida and Danziger-Isakov, Lara (2021). The evolution of the ISHLT transplant registry : preparing for the future. Journal of Heart and Lung Transplantation, 40 (12), 1670-1681. doi: 10.1016/j.healun.2021.09.007 |
|
2021 Journal Article High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trialDowman, Leona M., May, Anthony K., Hill, Catherine J., Bondarenko, Janet, Spencer, Lissa, Morris, Norman R., Alison, Jennifer A., Walsh, James, Goh, Nicole S. L., Corte, Tamera, Glaspole, Ian, Chambers, Daniel C., McDonald, Christine F. and Holland, Anne E. (2021). High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial. BMC Pulmonary Medicine, 21 (1) 361, 361. doi: 10.1186/s12890-021-01704-2 |
|
2021 Journal Article Donor to recipient matching for lung transplant candidates with interstitial lung disease: a sizeable problemEberlein, Michael and Chambers, Daniel C. (2021). Donor to recipient matching for lung transplant candidates with interstitial lung disease: a sizeable problem. Journal of Heart and Lung Transplantation, 40 (11), 1431-1432. doi: 10.1016/j.healun.2021.07.023 |
